ACRS FY 2021 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$7M+4.3% YoY

Gross Profit

$2M30.3% margin

Operating Income

-$90M-1327.1% margin

Net Income

-$91M-1344.0% margin

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$251M

Total Liabilities

$54M

Stockholders' Equity

$197M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+4.3%
Gross Profit	$2M	$1M	+51.8%
Operating Income	-$90M	-$51M	-76.2%
Net Income	-$91M	-$51M	-78.1%